Refining General Principles of Antiepileptic Drug Treatments for Epilepsy

다국어 초록 (Multilingual Abstract)

Antiepileptic drugs (AEDs) are the primary treatment strategy for epilepsy. As the use of AEDs has become more widespread and diverse over the past century, it has become necessary to refine the associated prescription strategies. This prompted the Drug Committee of the Korean Epilepsy Society to perform a systemic review of both international and domestic guidelines as well as literature related to medical treatment of epilepsy, and prepared a series of reviews to provide practical guidelines for clinicians to follow. This article is the first in a series on AED treatments for epilepsy in South Korea.

참고문헌 (Reference)

1 Braun KP, "Stopping antiepileptic drugs in seizure-free patients" 27 : 219-226, 2014

2 Betjemann JP, "Status epilepticus in adults" 14 : 615-624, 2015

3 Berg AT, "Risk of recurrence after a first unprovoked seizure" 49 (49): 13-18, 2008

4 Tang X, "Risk factors for seizure reoccurrence after withdrawal from antiepileptic drugs in individuals who have been seizure-free for over 2 years" 12 : e0181710-, 2017

5 Amstutz U, "Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions" 55 : 496-506, 2014

6 French JA, "Rational polytherapy" 50 (50): 63-68, 2009

7 "Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group)" 43 : 478-483, 1993

8 Ministry of Food and Drug Safety, "Pharmaceutical integrated information system" Ministry of Food and Drug Safety

9 Chadwick D, "Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group" 37 : 1043-1050, 1996

10 Anderson GD, "Modified-release formulations of secondgeneration antiepileptic drugs: pharmacokinetic and clinical aspects" 29 : 669-681, 2015

11 Mintzer S, "Metabolic consequences of antiepileptic drugs" 23 : 164-169, 2010

12 Chamberlain JM, "Lorazepam vs diazepam for pediatric status epilepticus : a randomized clinical trial" 311 : 1652-1660, 2014

13 Ou S, "Long-term outcome of seizure-free patients and risk factors of relapse following antiepileptic drug withdrawal" 88 : 295-300, 2018

14 Skirrow C, "Long-term intellectual outcome after temporal lobe surgery in childhood" 76 : 1330-1337, 2011

15 Lamberink HJ, "Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis" 16 : 523-531, 2017

16 Marson A, "Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures : a randomised controlled trial" 365 : 2007-2013, 2005

17 Glauser T, "ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes" 47 : 1094-1120, 2006

18 Fisher RS, "ILAE official report : a practical clinical definition of epilepsy" 55 : 475-482, 2014

19 Scheffer IE, "ILAE classification of the epilepsies : position paper of the ILAE Commission for Classification and Terminology" 58 : 512-521, 2017

20 McCormack M, "HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans" 364 : 1134-1143, 2011

21 Leppik IE, "Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations" 54 : 28-35, 2013

22 Krumholz A, "Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society" 84 : 1705-1713, 2015

23 이서영, "Estimating the Prevalence of Treated Epilepsy Using Administrative Health Data and Its Validity: ESSENCE Study" 대한신경과학회 12 (12): 434-440, 2016

24 Lee SK, "Epilepsy in the elderly : treatment and consideration of co-morbid diseases" 9 : 27-35, 2019

25 Thijs RD, "Epilepsy in adults" 393 : 689-701, 2019

26 Moshé SL, "Epilepsy : new advances" 385 : 884-898, 2015

27 Biton V, "Effect of antiepileptic drugs on bodyweight : overview and clinical implications for the treatment of epilepsy" 17 : 781-791, 2003

28 Lee SA, "Disclosure management behaviors in Korean adults with well-controlled epilepsy:their relation to perception of stigma" 67 : 28-32, 2017

29 Kwan P, "Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies" 51 : 1069-1077, 2010

30 Brodie MJ, "Combining antiepileptic drugs--rational polytherapy?" 20 : 369-375, 2011

31 Schneider-von Podewils F, "Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy : 20-65 years of follow-up" 55 : 322-330, 2014

32 French JA, "Clinical practice. Initial management of epilepsy" 359 : 166-176, 2008

33 Lee BI, "Clinical opinion : earlier employment of polytherapy in sequential pharmacotherapy of epilepsy" 156 : 106165-, 2019

34 Korean Epilepsy Society, "Clinical guideline for antiepileptic drug treatment in patient with epilepsy"

35 Chen P, "Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan" 364 : 1126-1133, 2011

36 Man CB, "Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese" 48 : 1015-1018, 2007

37 Bao EL, "Antiepileptic drug treatment after an unprovoked first seizure : a decision analysis" 91 : e1429-e1439, 2018

38 Cramer JA, "Adverse effects of antiepileptic drugs : a brief overview of important issues" 10 : 885-891, 2010

39 Perucca P, "Adverse effects of antiepileptic drugs" 11 : 792-802, 2012

40 Trinka E, "A definition and classification of status epilepticus--report of the ILAE Task Force on Classification of Status Epilepticus" 56 : 1515-1523, 2015

41 Alldredge BK, "A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus" 345 : 631-637, 2001

42 Trinka E, "25 years of advances in the definition, classification and treatment of status epilepticus" 44 : 65-73, 2017